Showing results (1441-1450 of 1,501) with videos related to

Sort By:
Pageof 151
Science Translational Medicine|July 19, 2023
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicityErica R Vander Mause, Jillian M Baker, Kenneth A Dietze, et al.
Journal of Pediatric Ophthalmology and Strabismus|September 21, 2020
Development of Screening Criteria for Retinopathy of Prematurity in Ulaanbaatar, Mongolia, Using a Web-based Data Management SystemShelbi L Olson, Tsengelmaa Chuluunbat, Emily D Cole, et al.
Blood|January 11, 2022
Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemiaHeeJin Cheon, Jeffrey C Xing, Katharine B Moosic, et al.
Antimicrobial Resistance and Infection Control|August 31, 2021
Admission screening and cohort care decrease carbapenem resistant enterobacteriaceae in Vietnamese pediatric ICU'sK Garpvall, V Duong, S Linnros, et al.
Frontiers in Immunology|November 5, 2024
Activating <i>STAT3</i> mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritisKatharine B Moosic, Thomas L Olson, Mark Freijat, et al.
Transplantation and Cellular Therapy|May 4, 2026
Third-Party Viral Specific T cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCTStella M Davies, Emily Blyth, Catherine M Bollard, et al.
The Journal of Experimental Biology|November 13, 2025
Daily energetic expenditure and energy consumption of short-finned pilot whalesWilliam T Gough, Brijonnay C Madrigal, Augusta Hollers, et al.
Circulation|September 1, 2004
Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trialM R Bristow, H Krause-Steinrauf, R Nuzzo, et al.
Cancer|January 20, 2021
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndromeBetül Oran, Rima M Saliba, Rohtesh S Mehta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2019
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up ResultsKamal Chamoun, Denái R Milton, Celina Ledesma, et al.
Pageof 151